- This event has passed.
The Future of Immune Cell Therapy
May 17 @ 7:00 pm - 9:00 pm
Join the Cell and Gene Therapy Committee for a Bay Area discussion on the future of immune cell therapy. Panelists will share their experience and insights on the current state of the field and strategies for how to move it forward. Topics will include:
- “Next-gen” autologous or Allogeneic?
- Which cell types seem to hold the greatest promise (CAR-T, TCR, CAR-NK, other?)
- Are solid tumor treatments coming soon?
- What are the clinical and CMC challenges?
The Cell and Gene Therapy Committee is co-chaired by Jens Vogel, SVP and Global Head of Biotech at Bayer, and Jeff Bluestone, CEO and President at Sonoma Biotherapeutics, and they will co-moderate the conversation. Audience members are invited to participate in this interactive conversation.
This meeting is reserved for industry companies engaged in cell and gene therapy research, development and commercialization. Service providers will be admitted on approval by the Committee chairs.
- May 17
7:00 pm - 9:00 pm